Cervical Cancer Vaccines Market
- 2026 年市場規模
- USD 14.78 Bn
- 2033 年預估規模
- USD 53.6 Bn
- 年複合成長率 CAGR
- 17.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Cervical Cancer Vaccines Market, By Product Type (Cervarix, Gardasil, and Gardasil 9), By Distribution Channel (Hospitals, Clinics, and Government Entities), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Cervical cancer is a common type of cancer occurring in women worldwide. A major cause of cervical cancer is infection by human papillomavirus (HPV), which is found in 99% cervical cancer. Human papillomavirus is sexually transmitted. Around 100 types of HPV have been identified to date, of which types 16 and 18 are believed to be responsible for more than 70% of cervical cancers. Cervarix and Gardasil are type of vaccines used for the treatment of cervical cancer.
Market Dynamics
Increasing prevalence of cervical cancer worldwide is expected to boost the cervical cancer vaccines market growth. According to the World Health Organization (WHO), 2018, cervical cancer is the fourth most frequent cancer in women with an estimated 570,000 new cases and representing 6.6% of all female cancers worldwide and around 85% of deaths occur due to cervical cancer in developing countries.
However, lack of awareness amongst the people in the low-income and middle-income countries regarding cervical cancer is expected to hinder growth of the cervical cancer vaccines market during the forecast period. Cervical cancer is one of the most common cancers among women of reproductive age in low-income and middle-income countries. For instance, according to The International Agency for Research on Cancer’s (IARC) report of 2013, cervical cancer is most notable in low-income countries of sub-Saharan Africa.
Key features of the study
• This report provides in-depth analysis of the global cervical cancer vaccines market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2026, considering 2018 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the cervical cancer vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, GlaxoSmithKline plc. and Merck & Co. Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The cervical cancer vaccines market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• By Product Type
o Cervarix
o Gardasil
o Gardasil 9
• By Distribution Channel
o Hospitals
o Clinics
o Government Entities
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o GlaxoSmithKline PLC
o Merck & Co. Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
PEST Analysis
PORTER’s Five Forces Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend
4. Global Cervical Cancer Vaccines Market, By Product Type, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Cervarix
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Gardasil
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Gardasil 9
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global Cervical Cancer Vaccines Market, By Distribution Channel, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Hospitals
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Clinics
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Government Entities
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
6. Global Cervical Cancer Vaccines Market, By Region, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
o North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o South Africa
o North Africa
o Central Africa
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
GlaxoSmithKline PLC
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Merck & Co. Inc.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
8. Analyst Recommendation
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們